← All stocks

Moderna

MRNA Scheduled selling only
CIK 0001682852 #318 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$64.63M
$278.86K on a plan · $64.36M straight out of an exercise
Sold at will
$0.00
0 of 19 sales
Net
−$64.63M
$0.00 against sales at will

By person

12 insiders · 21 transactions
1,362×

Stéphane Bancel holds 1,362 times base salary in stock. $2.29B of shares against $1.68M in salary for 2025.

Salary from the company's own proxy. The shares are what Stéphane Bancel last reported holding, valued at $146.07, the price Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Bancel Stephane
Chief Executive Officer
$28.72M (4) scheduled
−$28.72M
15,650,946
3.92%
$2.29B
+7.7%
Hoge Stephen
President
$28.43M (6) scheduled
−$28.43M
1,718,078
0.4303%
$250.96M
+7.4%
Mock James M
Chief Financial Officer
$4.69M (2) scheduled
−$4.69M
59,375
0.0149%
$8.67M
+577.3%
Klinger Shannon Thyme
Chief Legal Officer
$1.39M (3) scheduled
−$1.39M
81,340
0.0204%
$11.88M
+326.1%
AFEYAN NOUBAR
Director
$1.14M (2) scheduled
−$1.14M
3,924
0.0010%
$573.18K
0.0%
Hussain Abbas
Director
$278.86K (2) scheduled
−$278.86K
12,066
0.0030%
$1.76M
SAGAN PAUL
Director
312,027
0.0782%
$45.58M
+11.3%
Nader Francois
Director
32,781
0.0082%
$4.79M
+59.1%
NABEL ELIZABETH G
Director
19,317
0.0048%
$2.82M
+817.7%
Horning Sandra
Director
18,585
0.0047%
$2.71M
+1,254%
Rubenstein David M.
Director
9,643
0.0024%
$1.41M
Tallett Elizabeth E
Director
4,761
0.0012%
$695.44K
+577.2%
Insider
Date
Role
Action
Shares
Price
Amount
Hoge Stephen
15 Sep 2026
President
Sold after exercise
40,281
$146.07
$5.88M
Hoge Stephen
14 Sep 2026
President
Sold after exercise
40,294
$144.13
$5.81M
Mock James M
10 Sep 2026
Chief Financial Officer
Sold after exercise
15,000
$134.49
$2.02M
Mock James M
10 Sep 2026
Chief Financial Officer
Sold after exercise
19,836
$134.49
$2.67M
Klinger Shannon Thyme
1 Sep 2026
Chief Legal Officer
Sold after exercise
3,471
$139.95
$485.77K
Bancel Stephane
6 Aug 2026
Chief Executive Officer
Exercised, kept
252,469
$19.15
$4.83M
Bancel Stephane
5 Aug 2026
Chief Executive Officer
Sold after exercise
187,044
$58.79
$11.00M
Bancel Stephane
5 Aug 2026
Chief Executive Officer
Sold after exercise
39,891
$58.12
$2.32M
Bancel Stephane
5 Aug 2026
Chief Executive Officer
Sold after exercise
124,838
$56.96
$7.11M
Bancel Stephane
5 Aug 2026
Chief Executive Officer
Sold after exercise
147,473
$56.21
$8.29M
Hoge Stephen
15 Jul 2026
President
Sold after exercise
53,336
$67.60
$3.61M
Hoge Stephen
15 Jun 2026
President
Sold after exercise
53,336
$51.37
$2.74M
Klinger Shannon Thyme
4 Jun 2026
Chief Legal Officer
Sold after exercise
3,471
$50.00
$173.55K
AFEYAN NOUBAR
21 May 2026
Director
Sold after exercise indirect
9,263
$46.84
$433.88K
Hoge Stephen
15 May 2026
President
Sold after exercise
53,336
$48.40
$2.58M
Hussain Abbas
1 May 2026
Director
Sold on a plan
5,682
$46.63
$264.95K
Klinger Shannon Thyme
2 Mar 2026
Chief Legal Officer
Sold after exercise
13,885
$52.29
$726.05K
Hoge Stephen
23 Feb 2026
President
Sold after exercise
160,009
$48.84
$7.81M
Bancel Stephane
11 Dec 2025
Chief Executive Officer
Exercised, kept
688,073
$10.90
$7.50M
AFEYAN NOUBAR
11 Dec 2025
Director
Sold after exercise indirect
23,853
$29.49
$703.31K
Hussain Abbas
9 Dec 2025
Director
Sold on a plan
504
$27.60
$13.91K

What was left out

Form 4 filings counted 64
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 17
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,498,345
History held since 13 Dec 2018